C12N 2720/12121
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2720/12121 (Viruses as such) appears on 4 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 4
- Assignees
- 7
- Inventors
- 13
- Latest grant
- 1 Nov 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 1 |
| 2020 | 2 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
By publication year.
Recent patents
- Epizootic hemorrhagic disease virus—tel aviv university (EHDV-TAU)—oncolytic virus for treating cancer1 Nov 2022US 11,484,558 B2Ramot at Tel-Aviv University Ltd.
- Reassortant BTV and AHSV vaccines13 Oct 2020US 10,801,039 B2Boehringer Ingelheim Animal Health USA Inc.
- Reoviridae vaccine23 Jun 2020US 10,688,176 B2London School of Hygiene and Tropical Medicine
- Vaccines for diseases caused by viruses of the family of reoviridae20 Mar 2018US 9,919,044 B2Stichting Wageningen Research
- Reoviridae vaccine28 Feb 2019US 2019/0060442 A1London School of Hygiene and Tropical Medicine
- Epizootic hemorrhagic disease virus - tel aviv university (ehdv-tau) - oncolytic virus for treating cancer27 Dec 2018US 2018/0369302 A1Ramot at Tel-Aviv University Ltd.
- Vaccines for diseases caused by viruses of the family of reoviridae9 Jun 2016US 2016/0158342 A1Stichting Dienst Landbouwkundig Onderzoek
- Reassortant btv and ahsv vaccines19 Dec 2013US 2013/0337010 A1Merial Limited
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.